Global Lysosomal Alpha Glucosidase Market By Product Type (AT-982, ATB-200) And By End-Users/Application (Glycogen Storage Disease, Pompe Disease) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-790313
  • January 2021
  • Pharmaceuticals
  • 94 Pages
According to Apex Market Research the Lysosomal Alpha Glucosidase market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Lysosomal Alpha Glucosidase market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Lysosomal Alpha Glucosidase industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Lysosomal Alpha Glucosidase ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Lysosomal Alpha Glucosidase market.

The following manufacturers are covered in this report:
  • Amicus Therapeutics Inc
  • Audentes Therapeutics Inc
  • Etubics Corp
  • Genzyme Corp
  • greenovation Biotech GmbH
  • Huons Co Ltd
  • JCR Pharmaceuticals Co Ltd
  • Oxyrane Belgium NV
  • Pharming Group NV
  • Sarepta Therapeutics Inc

The report estimates on the Lysosomal Alpha Glucosidase market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Lysosomal Alpha Glucosidase market report consist of all leading industry players, Lysosomal Alpha Glucosidase business sections, company profile, revenue supply by Lysosomal Alpha Glucosidase industry sections, global Lysosomal Alpha Glucosidase market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Lysosomal Alpha Glucosidase market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Lysosomal Alpha Glucosidase market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Lysosomal Alpha Glucosidase market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Lysosomal Alpha Glucosidase market.

Report Opportunity: Global Lysosomal Alpha Glucosidase Market

This report delivers an analytical examination of the Lysosomal Alpha Glucosidase market summarized in broad sections such as
  1. Lysosomal Alpha Glucosidase Market Summary
  2. Key Commercial Growths in the Lysosomal Alpha Glucosidase Industry
  3. Market Dynamics Affecting the Lysosomal Alpha Glucosidase Industry
  4. Important Market Trends and Future Development Scenario of the Lysosomal Alpha Glucosidase Market
  5. Lysosomal Alpha Glucosidase Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Lysosomal Alpha Glucosidase Industry
  7. Positioning of Main Market Players in the Lysosomal Alpha Glucosidase Industry
  8. Lysosomal Alpha Glucosidase Market Revenue and Forecast, by Application, 2018 - 2028
  9. Lysosomal Alpha Glucosidase Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Lysosomal Alpha Glucosidase Market Revenue and Forecast, by Geography, 2018 - 2028
Lysosomal Alpha Glucosidase Market Segmentation:

The report provides detailed examination of the Lysosomal Alpha Glucosidase market on the basis of various segments such as type, application and end-use industry. The Lysosomal Alpha Glucosidase market is segmented as follows:

Lysosomal Alpha Glucosidase Market, by Type:
  • AT-982
  • ATB-200
  • AVRRD-03
  • JR-162
  • MOSS-GAA
  • OXY-2810
  • Others
Lysosomal Alpha Glucosidase Market, by Application:
  • Glycogen Storage Disease
  • Pompe Disease
  • Others
Geographic Coverage

The report on the Lysosomal Alpha Glucosidase market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Lysosomal Alpha Glucosidase Market Revenue and Forecast
  • U.S.
  • Canada
Europe Lysosomal Alpha Glucosidase Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Lysosomal Alpha Glucosidase Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Lysosomal Alpha Glucosidase Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Lysosomal Alpha Glucosidase Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Lysosomal Alpha Glucosidase Market Snapshot
          2.1.1. Global Lysosomal Alpha Glucosidase Market By Type,2019
               2.1.1.1.AT-982
               2.1.1.2.ATB-200
               2.1.1.3.AVRRD-03
               2.1.1.4.JR-162
               2.1.1.5.MOSS-GAA
               2.1.1.6.OXY-2810
               2.1.1.7.Others
          2.1.2. Global Lysosomal Alpha Glucosidase Market By Application,2019
               2.1.2.1.Glycogen Storage Disease
               2.1.2.2.Pompe Disease
               2.1.2.3.Others
          2.1.3. Global Lysosomal Alpha Glucosidase Market By End-use,2019
          2.1.4. Global Lysosomal Alpha Glucosidase Market By Geography,2019

3. Global Lysosomal Alpha Glucosidase Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Lysosomal Alpha Glucosidase Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Lysosomal Alpha Glucosidase Market Size (US$), By Type, 2018 – 2028

5. Global Lysosomal Alpha Glucosidase Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Lysosomal Alpha Glucosidase Market Size (US$), By Application, 2018 – 2028

6. Global Lysosomal Alpha Glucosidase Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Lysosomal Alpha Glucosidase Market Size (US$), By End-use, 2018 – 2028

7. Global Lysosomal Alpha Glucosidase Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Lysosomal Alpha Glucosidase Market Analysis, 2018 – 2028 
          7.2.1. North America Lysosomal Alpha Glucosidase Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Lysosomal Alpha Glucosidase Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Lysosomal Alpha Glucosidase Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Lysosomal Alpha Glucosidase Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Lysosomal Alpha Glucosidase Market Analysis, 2018 – 2028 
          7.3.1.  Europe Lysosomal Alpha Glucosidase Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Lysosomal Alpha Glucosidase Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Lysosomal Alpha Glucosidase Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Lysosomal Alpha Glucosidase Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Lysosomal Alpha Glucosidase Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Lysosomal Alpha Glucosidase Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Lysosomal Alpha Glucosidase Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Lysosomal Alpha Glucosidase Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Lysosomal Alpha Glucosidase Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Lysosomal Alpha Glucosidase Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Lysosomal Alpha Glucosidase Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Lysosomal Alpha Glucosidase Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Lysosomal Alpha Glucosidase Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Lysosomal Alpha Glucosidase Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Lysosomal Alpha Glucosidase Market Analysis, 2018 – 2028 
          7.6.1.  MEA Lysosomal Alpha Glucosidase Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Lysosomal Alpha Glucosidase Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Lysosomal Alpha Glucosidase Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Lysosomal Alpha Glucosidase Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Lysosomal Alpha Glucosidase Providers
        8.4.1 Amicus Therapeutics Inc
                8.1.1 Business Description
                8.1.2 Amicus Therapeutics Inc Geographic Operations
                8.1.3 Amicus Therapeutics Inc Financial Information
                8.1.4 Amicus Therapeutics Inc Product Positions/Portfolio
                8.1.5 Amicus Therapeutics Inc Key Developments
        8.4.2 Audentes Therapeutics Inc
                8.2.1 Business Description
                8.2.2 Audentes Therapeutics Inc Geographic Operations
                8.2.3 Audentes Therapeutics Inc Financial Information
                8.2.4 Audentes Therapeutics Inc Product Positions/Portfolio
                8.2.5 Audentes Therapeutics Inc Key Developments
        8.4.3 Etubics Corp
                8.3.1 Business Description
                8.3.2 Etubics Corp Geographic Operations
                8.3.3 Etubics Corp Financial Information
                8.3.4 Etubics Corp Product Positions/Portfolio
                8.3.5 Etubics Corp Key Developments
        8.4.4 Genzyme Corp
                8.4.1 Business Description
                8.4.2 Genzyme Corp Geographic Operations
                8.4.3 Genzyme Corp Financial Information
                8.4.4 Genzyme Corp Product Positions/Portfolio
                8.4.5 Genzyme Corp Key Developments
        8.4.5 greenovation Biotech GmbH
                8.5.1 Business Description
                8.5.2 greenovation Biotech GmbH Geographic Operations
                8.5.3 greenovation Biotech GmbH Financial Information
                8.5.4 greenovation Biotech GmbH Product Positions/Portfolio
                8.5.5 greenovation Biotech GmbH Key Developments
        8.4.6 Huons Co Ltd
                8.6.1 Business Description
                8.6.2 Huons Co Ltd Geographic Operations
                8.6.3 Huons Co Ltd Financial Information
                8.6.4 Huons Co Ltd Product Positions/Portfolio
                8.6.5 Huons Co Ltd Key Developments
        8.4.7 JCR Pharmaceuticals Co Ltd
                8.7.1 Business Description
                8.7.2 JCR Pharmaceuticals Co Ltd Geographic Operations
                8.7.3 JCR Pharmaceuticals Co Ltd Financial Information
                8.7.4 JCR Pharmaceuticals Co Ltd Product Positions/Portfolio
                8.7.5 JCR Pharmaceuticals Co Ltd Key Developments
        8.4.8 Oxyrane Belgium NV
                8.8.1 Business Description
                8.8.2 Oxyrane Belgium NV Geographic Operations
                8.8.3 Oxyrane Belgium NV Financial Information
                8.8.4 Oxyrane Belgium NV Product Positions/Portfolio
                8.8.5 Oxyrane Belgium NV Key Developments
        8.4.9 Pharming Group NV
                8.9.1 Business Description
                8.9.2 Pharming Group NV Geographic Operations
                8.9.3 Pharming Group NV Financial Information
                8.9.4 Pharming Group NV Product Positions/Portfolio
                8.9.5 Pharming Group NV Key Developments
        8.4.10 Sarepta Therapeutics Inc
                8.10.1 Business Description
                8.10.2 Sarepta Therapeutics Inc Geographic Operations
                8.10.3 Sarepta Therapeutics Inc Financial Information
                8.10.4 Sarepta Therapeutics Inc Product Positions/Portfolio
                8.10.5 Sarepta Therapeutics Inc Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Lysosomal Alpha Glucosidase Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Lysosomal Alpha Glucosidase Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Lysosomal Alpha Glucosidase Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Lysosomal Alpha Glucosidase Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Lysosomal Alpha Glucosidase Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Lysosomal Alpha Glucosidase Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Lysosomal Alpha Glucosidase Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Lysosomal Alpha Glucosidase Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Lysosomal Alpha Glucosidase Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Lysosomal Alpha Glucosidase Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Lysosomal Alpha Glucosidase Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Lysosomal Alpha Glucosidase Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Lysosomal Alpha Glucosidase Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Lysosomal Alpha Glucosidase Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Lysosomal Alpha Glucosidase Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Lysosomal Alpha Glucosidase Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Lysosomal Alpha Glucosidase: Market Segmentation 
FIG. 2 Global Lysosomal Alpha Glucosidase Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Lysosomal Alpha Glucosidase Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Lysosomal Alpha Glucosidase Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Lysosomal Alpha Glucosidase Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Lysosomal Alpha Glucosidase Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Lysosomal Alpha Glucosidase Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Lysosomal Alpha Glucosidase Providers, 2019
FIG. 11 Global Lysosomal Alpha Glucosidase Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Lysosomal Alpha Glucosidase Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Lysosomal Alpha Glucosidase Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Lysosomal Alpha Glucosidase Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Lysosomal Alpha Glucosidase Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Lysosomal Alpha Glucosidase Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Lysosomal Alpha Glucosidase Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Lysosomal Alpha Glucosidase Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Lysosomal Alpha Glucosidase market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Market Value, By Segment1, 2018 – 2028
TABLE  North America Market Value, By Segment2, 2018 – 2028
TABLE  North America Market Value, By Country, 2018 – 2028
TABLE  Europe Market Value, By Segment1, 2018 – 2028
TABLE  Europe Market Value, By Segment2, 2018 – 2028
TABLE  Europe Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Market Value, By Country, 2018 – 2028
TABLE  Latin America Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Market Value, By Country, 2018 – 2028
TABLE  MEA Market Value, By Segment1, 2018 – 2028
TABLE  MEA Market Value, By Segment2, 2018 – 2028
TABLE  MEA Market Value, By Country, 2018 – 2028
 

List of Figures

FIG.  Global Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Market, By Geography, 2019 (US$ Mn)
FIG.  Global Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Providers, 2016
FIG.  Global Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  U.S. Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Market Value, 2018 – 2028, (US$ Mn)